Screener
Aflac AFL Cancer — Liability for Future Policy Benefit, after Reinsurance
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aflac in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance.
The source filing: Aflac’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 9:18 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054618
| (In millions) | Aflac Japan / Cancer | Aflac Japan / Medicaland Other Health | Aflac Japan / Life Insurance | Aflac Japan / Other | Aflac U.S. / Accident | Aflac U.S. / Disability | Aflac U.S. / Critical Care | Aflac U.S. / Hospital Indemnity | Aflac U.S. / Dental/Vision | Aflac U.S. / Life Insurance | Aflac U.S. / Other |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreign currency translation | (1,293) | (782) | (903) | (168) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ending balance at original discount rate | 34,634 | 20,959 | 24,121 | 4,515 | 3,300 | 2,408 | 11,833 | 2,080 | 458 | 2,422 | 2,791 |
| Effect of changes in discount rate assumptions | (3,323) | (5,274) | (5,681) | (1,254) | (210) | (98) | (1,146) | (144) | (27) | (243) | 167 |
| Balance at June 30, 2026 | 31,311 | 15,685 | 18,440 | 3,261 | 3,090 | 2,310 | 10,687 | 1,936 | 431 | 2,179 | 2,958 |
| Net liability for future policy benefits | 20,325 | 6,504 | 14,357 | 2,625 | 635 | 627 | 6,746 | 758 | 228 | 1,091 | 471 |
| Less: reinsurance recoverable | 3,920 | 933 | 303 | 0 | 0 | 0 | 0 | 0 | 0 | 29 | 17 |
| Net liability for future policy benefits after reinsurance recoverable | $16,405 | $5,571 | $14,054 | $2,625 | $635 | $627 | $6,746 | $758 | $228 | $1,062 | $454 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Aflac's cancer — liability for future policy benefit, after reinsurance?
- Aflac (AFL) reported cancer — liability for future policy benefit, after reinsurance of $16.41B in Q2 2026.
- How has Aflac's cancer — liability for future policy benefit, after reinsurance changed year-over-year?
- Aflac's cancer — liability for future policy benefit, after reinsurance decreased by 24.8% year-over-year, from $21.82B to $16.41B.
- What is the long-term trend for Aflac's cancer — liability for future policy benefit, after reinsurance?
- Over 2 years (2023 to 2025), Aflac's cancer — liability for future policy benefit, after reinsurance has grown at a -14.5% compound annual growth rate (CAGR), from $112.45B to $82.11B.
- What does cancer — liability for future policy benefit, after reinsurance mean?
- This represents the actuarial estimate of the present value of future benefits payable to policyholders in the cancer insurance segment, net of any reinsurance recoveries. It reflects the long-term financial obligation the company must hold to cover future claims for this specific product line. This metric is critical for assessing the long-term solvency and reserve adequacy of the cancer insurance business.
Ask your AI about Aflac's cancer — liability for future policy benefit, after reinsurance.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude